DE69333009D1 - Transdermale verabreichung von ketorolac - Google Patents

Transdermale verabreichung von ketorolac

Info

Publication number
DE69333009D1
DE69333009D1 DE69333009T DE69333009T DE69333009D1 DE 69333009 D1 DE69333009 D1 DE 69333009D1 DE 69333009 T DE69333009 T DE 69333009T DE 69333009 T DE69333009 T DE 69333009T DE 69333009 D1 DE69333009 D1 DE 69333009D1
Authority
DE
Germany
Prior art keywords
ketorolac
transdermal administration
transdermal
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69333009T
Other languages
English (en)
Other versions
DE69333009T2 (de
Inventor
Judy M Mohr
Richard W Baker
Lisa A Nakaji
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NeurogesX Inc
Original Assignee
NeurogesX Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NeurogesX Inc filed Critical NeurogesX Inc
Application granted granted Critical
Publication of DE69333009D1 publication Critical patent/DE69333009D1/de
Publication of DE69333009T2 publication Critical patent/DE69333009T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69333009T 1992-11-09 1993-11-09 Transdermale verabreichung von ketorolac Expired - Fee Related DE69333009T2 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US97380192A 1992-11-09 1992-11-09
US881493A 1993-01-22 1993-01-22
US1025693A 1993-01-25 1993-01-25
PCT/US1993/010761 WO1994010986A1 (en) 1992-11-09 1993-11-09 Transdermal delivery of ketorolac

Publications (2)

Publication Number Publication Date
DE69333009D1 true DE69333009D1 (de) 2003-07-03
DE69333009T2 DE69333009T2 (de) 2003-12-04

Family

ID=27358714

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69333009T Expired - Fee Related DE69333009T2 (de) 1992-11-09 1993-11-09 Transdermale verabreichung von ketorolac

Country Status (6)

Country Link
EP (1) EP0668759B1 (de)
JP (1) JPH08503465A (de)
AU (1) AU5596394A (de)
DE (1) DE69333009T2 (de)
ES (1) ES2199954T3 (de)
WO (1) WO1994010986A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6682757B1 (en) * 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system
PT1406633E (pt) 2001-06-18 2012-01-12 Noven Pharma Distribuição melhorada de fármacos em sistemas transdérmicos
BRPI0302736B8 (pt) 2003-06-02 2021-05-25 Ems S/A composição farmacêutica a base de cetorolaco ou de um de seus sais farmaceuticamente aceitáveis para uso sublingual
CA2790749A1 (en) * 2011-09-29 2013-03-29 Nitto Denko Corporation Manufacturing method of patch preparation

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4752478A (en) * 1984-12-17 1988-06-21 Merck & Co., Inc. Transdermal system for timolol
ES2043719T3 (es) * 1987-06-12 1994-01-01 American Cyanamid Co Administracion de farmacos por via percutanea.
GB8804164D0 (en) * 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
JPH02149514A (ja) * 1988-04-06 1990-06-08 Nitto Denko Corp 医薬部材
US4910205A (en) * 1988-05-02 1990-03-20 Schering Corporation Transdermal delivery of loratadine
JP2781016B2 (ja) * 1989-08-24 1998-07-30 日東電工株式会社 経皮吸収製剤
DE3937271A1 (de) * 1989-11-09 1991-05-16 Boehringer Ingelheim Kg Transdermale applikation von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazol
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
JP3541849B2 (ja) * 1991-04-19 2004-07-14 久光製薬株式会社 消炎鎮痛貼付剤
JP2816765B2 (ja) * 1991-08-30 1998-10-27 久光製薬株式会社 消炎鎮痛貼付剤
JP3477211B2 (ja) * 1992-05-22 2003-12-10 久光製薬株式会社 ケトロラック含有リザーバー型貼付剤

Also Published As

Publication number Publication date
EP0668759A4 (de) 1996-01-24
EP0668759B1 (de) 2003-05-28
ES2199954T3 (es) 2004-03-01
AU5596394A (en) 1994-06-08
EP0668759A1 (de) 1995-08-30
DE69333009T2 (de) 2003-12-04
JPH08503465A (ja) 1996-04-16
WO1994010986A1 (en) 1994-05-26

Similar Documents

Publication Publication Date Title
DE69530004D1 (de) Transdermale verabreichung von apomorphin
DE69628448D1 (de) Transdermale verabreichungsform von flurbiprofen
DK42093D0 (da) Administrationsmetode
KR890020593U (ko) 가구 등의 보호각
DE69609353T2 (de) In der therapie verwendbare chinolin- und chinazolinverbindungen
DE69218932D1 (de) Transdermale therapeutische Formulierung
DE69319679D1 (de) Eingabe von Sonderbuchstaben
DE69332741D1 (de) Nachweis von hypoxia
DE69324288D1 (de) Beschleunigung- und Winkelbeschleunigungsmesser
DE68926733D1 (de) Piperidin-Derivate und diese enthaltende Hypotensiva
DE69325073D1 (de) Borazinderivate von Hydridopolysilazanpolymeren
DE69327537T2 (de) 17-beta-arylester carboxylate von 4-aza-5-alpha-androstan-3-one
DE69333009T2 (de) Transdermale verabreichung von ketorolac
NO940190D0 (no) Anvendelse av x-ketoglutarat
DK88790D0 (da) Terapeutisk virksomme midler
DE59209380D1 (de) Defibrillator
FI950029A0 (fi) Uusia analgeettisia ja nootrooppisia lääkeaineita
DK85290D0 (da) Terapeutisk virksomme forbindelser
FI945488A0 (fi) Tetrahydro- ja perhydroisokinoliinijohdannaiset ja niitä sisältävät terapeuttiset aineet
DK429589A (da) Transdermalt laegemiddelpraeparat
DE69218215D1 (de) Entfernung von schwefelwasserstoff
KR930026760U (ko) Tvcr의 개선된 구성
DE69313442T2 (de) Hydroxyderivate von cyclohexadien
ITMI922534A1 (it) Uso di acidi aril-, eteroaril- e alchiltartronici come agenti terapeutici
KR920021881U (ko) 최루분사용

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee